Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global Single-use Bioprocessing Systems Market, by Product Type (Instruments and Accessories), By Application (Monoclonal Antibody Production, Vaccine Production, Patient-Specific Cell Therapies, and Other Applications), and by End User (Biotechnology and Pharmaceutical Companies, Research & Academic Research Institutes, and Contract Research Organizations (CRO) & Contract Manufacturing Organizations(CMO)) is estimated to be valued at US$ 2.8 billion in 2018, and is estimated to exhibit a CAGR of 17.2% over the forecast period (2018-2026).
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/1754
Biopharmaceutical industry requires flexible manufacturing solutions to reduce timeline for drug development, reduce risks of cross contamination, and to enable fast, user-friendly, and efficient processing of biologics. Single-use systems are majorly adopted for storage bags for cell culture media and serum, which is a major trend in biopharmaceutical manufacturing. Moreover, single-use or disposable bioprocessing trend is inclined towards commercial-scale manufacturing, owing to the continuous development by key players in the market.
Moreover, key players are focusing on developing single-use bioprocessing systems and launching technologically advanced products for consumers. For instance, in October 2014, Merck introduced PureFlex Plus Single-Use process container film. This new single-use process container film was designed for high-volume biopharmaceutical applications. Similarly, in June 2015, Merck Group launched Mobius 2000 liter single-use bioreactor. The new Mobius 2000 liter single-use bioreactor is configured with software, hardware, and single-use Flexware assemblies for suspension and adherent cell culture applications. Furthermore, in September 2017, Pall Corporation, a subsidiary of Danaher Corporation launched Allegro single-use chromatography and Cadence continuous bioprocessing product portfolio. Both products enables scalable process integration for biopharmaceutical manufacturers.
In September 2016, Sartorius AG launched two Single-use Sartocon loop assemblies with integrated Polyethersulfone (PESU) membrane. The new single-use Sartocon self-contained filter loop assembly has been developed for use with company’s unique control unit, the FlexAct UD. Similarly in October 2014, Thermo Fisher Scientific launched new HyPerforma Single-Use Fermenter at the BioProcess International Conference and Exhibition. The new HyPerforma Single-Use Fermenter was specifically designed for microbial fermentation and to scale up from the lab to GMP production.
Browse 22 Market Data Tables and 39 Figures spread through 160 Pages and in-depth TOC on “Single-use Bioprocessing Systems Market, by Product Type (Instruments and Accessories), By Application (Monoclonal Antibody Production, Vaccine Production, Patient-Specific Cell Therapies and Other Applications), and by End User (Biotechnology and Pharmaceutical Companies, Research & Academic Research Institutes, and Contract Research Organizations(CRO) & Contract Manufacturing Organizations(CMO)) – Global Forecast to 2026″
To know the latest trends and insights related to single-use bioprocessing systems market Press Release, click the link below: https://bit.ly/33zDFjE
Furthermore, key players are focusing on strategic collaborations, agreements, and partnerships, which are expected to drive growth of the single-use bioprocessing systems market over the forecast period. For instance, in April 2018, Pall Corporation entered into a collaboration with its Biotech business unit, and Artesyn Biosolutions. Under the collaboration, both the companies will deliver complete solutions from clinical to commercial-scale for single-use automated bioprocessing systems.
Similarly, in April 2017, Applikon Biotechnology entered into a partnership with Sanyo Trading Scientific Instruments. Under the partnership, Applikon and Sanyo will showcase Applikon products to potential customers in Japan. Moreover, in August 2016, General Electric Company signed an exclusive agreement with Sealed Air Corporation. The agreement allows GE and Sealed Air to develop new primary film, which will be suitable for use in GE’s several single-use product portfolio. Furthermore, in June 2012, Applikon Biotechnology BV signed a bilateral supply agreement with Thermo Fisher Scientific Inc. Under the agreement, Thermo Fisher and Applikon developed a single-use bioreactor.
Key takeaways of the single-use bioprocessing systems market:
- The global single-use bioprocessing systems market is expected to exhibit a CAGR of 17.2% during the forecast period (2018-2026), attributed to technological advancements and increasing number of product launches by key players
- Among product type, accessories segment is expected to account for highest market share over the forecast period, attributed to its inevitable need in single-use bioprocessing and increasing adoption of disposable systems in upstream and downstream bioprocessing systems
- Among application, monoclonal antibody production segment is expected to account for highest market share over the forecast period, attributed to increasing need by biomanufactures to increase monoclonal antibody production at shorter time with lower cost
- Among end user, biotechnology and pharmaceutical companies segment is expected to account for highest market share over the forecast period, attributed to increasing application of single-use bioprocessing systems in the production of therapeutic and clinical biopharmaceutical products
- Key players operating in the global single-use bioprocessing systems market include Compagnie de Saint-Gobain S.A., Thermo Fisher Scientific Inc., Applikon Biotechnology BV, Parker-Hannifin Corporation, Sartorius AG, Eppendorf AG, Danaher Corporation, Merck KGaA, and General Electric Company, among others
Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1754
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027